These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34397557)

  • 1. Rectal Cancer in Adolescent and Young Adult Patients: Pattern of Clinical Presentation and Case-Matched Comparison of Outcomes.
    Foppa C; Francesca Bertuzzi A; Cianchi F; Carvello M; Maroli A; Wolthuis AM; Rimassa L; Laghi L; Montorsi M; D'Hoore AJL; Spinelli A
    Dis Colon Rectum; 2021 Sep; 64(9):1064-1073. PubMed ID: 34397557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
    Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
    Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
    Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
    Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Expanding Metal Stents Do Not Adversely Affect Long-term Outcomes in Acute Malignant Large-Bowel Obstruction: A Retrospective Analysis.
    Browne IL; Mahsin M; Drolet S; Buie WD; Heine JA; MacLean AR
    Dis Colon Rectum; 2022 Feb; 65(2):228-237. PubMed ID: 34990424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable Survival After Screening for Young-Onset Colorectal Cancer: Benefits of Screening in Young Adults.
    Takada K; Hotta K; Imai K; Ito S; Kishida Y; Ono H
    Dis Colon Rectum; 2022 Aug; 65(8):996-1004. PubMed ID: 34856591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Blood Transfusions Are Associated With Worse Overall Survival But Not Disease-Free Survival After Curative Rectal Cancer Resection: A Propensity Score-Matched Analysis.
    Hanna DN; Gamboa AC; Balch GC; Regenbogen SE; Holder-Murray J; Abdel-Misih SRZ; Silviera ML; Feng MP; Stewart TG; Wang L; Hawkins AT
    Dis Colon Rectum; 2021 Aug; 64(8):946-954. PubMed ID: 34214054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
    Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
    Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.
    Nishizaki D; Hida K; Sumii A; Okamura R; Sakai Y; Konishi T; Akiyoshi T; Maruyama S; Okajima M; Miyakura Y; Yamamoto S; Morita S; Watanabe M;
    Dis Colon Rectum; 2022 Aug; 65(8):1005-1014. PubMed ID: 34775411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and Outcomes of Right- Versus Left-Sided Early-Onset Colorectal Cancer.
    Tom CM; Mankarious MM; Jeganathan NA; Deutsch M; Koltun WA; Berg AS; Scow JS
    Dis Colon Rectum; 2023 Apr; 66(4):498-510. PubMed ID: 35001052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "Classification Pendulum" of Stage I Colorectal Cancer: A National Level Analysis of the Survival Difference Between T1 and T2 Colorectal Cancer.
    Allievi N; Goffredo P; Freischlag KW; Utria AF; Cromwell JW; Pisano M; Poiasina E; Hassan I
    Dis Colon Rectum; 2022 Apr; 65(4):505-518. PubMed ID: 34310516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
    Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Propensity Score-Matched Analysis of the Impact of Neoadjuvant Radiation Therapy on the Outcomes of Stage II and III Mucinous Rectal Carcinoma.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Wexner SD
    Dis Colon Rectum; 2024 May; 67(5):655-663. PubMed ID: 38231014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
    Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
    Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival.
    Gan T; Chen Q; Huerta CT; Huang B; Evers BM; Patel JA
    Dis Colon Rectum; 2021 Oct; 64(10):1212-1221. PubMed ID: 34516443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological Outcomes of Transanal Endoscopic Surgery for the Surgical Management of T2 and T3 Rectal Cancer.
    Johnson GGRJ; Robertson RL; Vergis A; Raval M; Phang T; Karimuddin A; Brown C
    Dis Colon Rectum; 2023 Jul; 66(7):1012-1021. PubMed ID: 36876985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.